Bank of America
EDIT icon

Bank of America’s Editas Medicine EDIT Stock Holding History

Bank of America’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-114,500
Closed -$4.7M – 8314
2021
Q3 		$4.7M Buy
+114,500
New +$6.27M ﹤0.01% 3624
2021
Q1 		– Sell
-50,200
Closed -$3.52M – 7495
2020
Q4 		$3.52M Buy
+50,200
New +$2.06M ﹤0.01% 3467

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America's EDIT Position: Q1 2026 in Review

Bank of America reduced its Editas Medicine (EDIT) stake by 30% in Q1 2026, selling an estimated $124K and leaving 134,866 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #5102.

Bank of America first reported a position in EDIT in Q1 2016 and has held it in 41 quarters since. The position peaked at $13.7M in Q2 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Bank of America held 134,866 shares of Editas Medicine worth $333K as of Q1 2026.
  • Bank of America sold 58,809 Editas Medicine shares in Q1 2026, an estimated $124K.
  • Editas Medicine made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5102 holding.
  • Bank of America first reported a position in Editas Medicine in Q1 2016 and has held it in 41 quarters since.
  • Bank of America's Editas Medicine position peaked at $13.7M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.